Signaling pathways
-
BA5085 TDI-10229Summary: TDI-10229 is an orally effective soluble adenylate cyclase inhibitor (value 195 nM). -
BA5086 ST034307Summary: ST034307 is a potent, selective inhibitor. -
BA5087 Fipexide -
BA5088 TDI-11861Summary: TDI-11861 is a second-generation inhibitor of soluble adenylate cyclase characterized by a slow dissociation rate. -
BA5089 LysipressinSummary: Lysipressin (Lysinevasopressin) is an antidiuretic hormone found in pigs. -
BA5090 CB-7921220Summary: Inhibitors of adenylate cyclase. -
BA5091 AC1-IN-1Summary: AC1-IN-1 is a potent and selective inhibitor. -
BA5092 NB001Summary: NB001 (HTS09836) is an adenylate cyclase 1 inhibitor. -
BA5093 Mant-GTPγSSummary: Mant-GTPγS, a GTP mimetic, is a potent competitive adenylate cyclase inhibitor. -
BA5094 HeptaminolSummary: Heptaminol is a fatty amine with antihypertensive properties and is a potential antihypertensive agent.

